VistaGen Therapeutics
VTGN
VTGN
46 hedge funds and large institutions have $90.1M invested in VistaGen Therapeutics in 2023 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 15 increasing their positions, 2 reducing their positions, and 12 closing their positions.
Holders
46
Holders Change
+12
Holders Change %
+35.29%
% of All Funds
0.67%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
15
Reduced
2
Closed
12
Calls
$5.29M
Puts
$571K
Net Calls
+$4.72M
Net Calls Change
+$589K
Top Buyers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
BFM
51
Boothbay Fund Management
New York
| – | – | -46,895 | Closed |
|
|
GCP
52
GSA Capital Partners
London,
United Kingdom
| – | – | -46,782 | Closed |
|
|
PCM
53
Prelude Capital Management
New York
| – | – | -20,200 | Closed |
|
54
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | – | -19,355 | Closed |
|
55
Millennium Management
New York
| – | – | -16,870 | Closed |
|
|
RJA
56
Raymond James & Associates
St Petersburg,
Florida
| – | – | -10,000 | Closed |
|
57
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | – | -1,192 | Closed |
|
58
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| – | – | -46 | Closed |
|
|
GS
59
GTS Securities
New York
| – | – | – | – |
|
|
CFGS
60
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|